Growth Metrics

SOPHiA GENETICS (SOPH) Cash from Investing Activities (2020 - 2025)

SOPHiA GENETICS's Cash from Investing Activities history spans 6 years, with the latest figure at -$3.5 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 178.02% to -$3.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.7 million, a 82.33% decrease, with the full-year FY2025 number at -$8.7 million, down 82.33% from a year prior.
  • Cash from Investing Activities hit -$3.5 million in Q4 2025 for SOPHiA GENETICS, down from -$2.6 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for SOPH hit a ceiling of $18.0 million in Q2 2022 and a floor of -$52.7 million in Q3 2021.
  • Historically, Cash from Investing Activities has averaged -$770550.0 across 5 years, with a median of -$1.2 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 7238.58% in 2021 and later soared 1044.1% in 2022.
  • Tracing SOPH's Cash from Investing Activities over 5 years: stood at -$1.3 million in 2021, then skyrocketed by 1043.12% to $12.1 million in 2022, then plummeted by 80.18% to $2.4 million in 2023, then crashed by 152.37% to -$1.3 million in 2024, then tumbled by 178.02% to -$3.5 million in 2025.
  • Business Quant data shows Cash from Investing Activities for SOPH at -$3.5 million in Q4 2025, -$2.6 million in Q3 2025, and -$1.6 million in Q2 2025.